Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration-Reference-Cited by-同舟云学术

Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration

Published:2020-05-19 Issue:5 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Damiani Giovanni¹²^ORCID,Pacifico Alessia³^ORCID,Bragazzi Nicola L.⁴,Malagoli Piergiorgio⁵

Affiliation:

1. Clinical Dermatology IRCCS Istituto Ortopedico Galeazzi Milan Italy

2. Department of Biomedical, Surgical and Dental Sciences University of Milan Milan Italy

3. Phototherapy Unit, San Gallicano Dermatological Hospital Rome Italy

4. Laboratory for Industrial and Applied Mathematics (LIAM) Department of Mathematics and Statistics, York University Toronto Canada

5. Dermatology Unit, Azienda Ospedaliera San Donato Milanese Milan Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13475

Reference9 articles.

1. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China

2. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis

3. Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy

4. Lifestyle changes for treating psoriasis;Ko SH;Cochrane Database Syst Rev,2019

5. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The flare up of immune-mediated inflammatory dermatoses during COVID-19 pandemic—a cross sectional study in a tertiary care hospital;Egyptian Journal of Dermatology and Venereology;2024-09

2. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30

3. A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting;Immunity, Inflammation and Disease;2023-11

4. Biologics and Biosimilars in Psoriasis;Indian Journal of Dermatology;2023-05

5. The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness;Current Dermatology Reports;2023-04-03